Publication:
Sex Differences in Patients With Occult Cancer After Venous Thromboembolism.

dc.contributor.authorJara-Palomares, Luis
dc.contributor.authorOtero, Remedios
dc.contributor.authorJiménez, David
dc.contributor.authorPraena-Fernández, Juan Manuel
dc.contributor.authorRivas, Agustina
dc.contributor.authorFont, Carme
dc.contributor.authorWells, Philip S
dc.contributor.authorLópez-Reyes, Raquel
dc.contributor.authorGonzález-Martínez, José
dc.contributor.authorMonreal, Manuel
dc.date.accessioned2023-01-25T09:48:30Z
dc.date.available2023-01-25T09:48:30Z
dc.date.issued2017-07-06
dc.description.abstractIn patients with venous thromboembolism (VTE), male sex has been associated with an increased risk of occult cancer. The influence of sex on clinical characteristics, treatment, cancer sites, and outcome has not been thoroughly investigated yet. We used the Registro Informatizado Enfermedad TromboEmbólica registry to compare the clinical characteristics, treatment strategies, cancer sites, and clinical outcomes in patients with VTE having occult cancer, according to sex. As of June 2014, 5864 patients were recruited, of whom 444 (7.6%; 95% confidence interval: 6.8-8.2) had occult cancer. Of these, 246 (55%) were men. Median time elapsed from VTE to occult cancer was 4 months (interquartile range: 2-8.4), with no sex differences. Women were older, weighed less, and were less likely to have chronic lung disease than men. The most common cancer sites were the lung (n = 63), prostate (n = 42), and colorectal (n = 29) in men and colorectal (n = 38), breast (n = 23), uterine (n = 18), hematologic (n = 17), or pancreas (n = 15) in women. Men were more likely to have lung cancer than women (2.18% vs 0.30%; P 50 years.
dc.identifier.doi10.1177/1076029617711805
dc.identifier.essn1938-2723
dc.identifier.pmcPMC6714663
dc.identifier.pmid28681634
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714663/pdf
dc.identifier.unpaywallURLhttps://journals.sagepub.com/doi/pdf/10.1177/1076029617711805
dc.identifier.urihttp://hdl.handle.net/10668/11377
dc.issue.number3
dc.journal.titleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
dc.journal.titleabbreviationClin Appl Thromb Hemost
dc.language.isoen
dc.organizationFundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla-FISEVI
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number489-495
dc.pubmedtypeJournal Article
dc.rights.accessRightsopen access
dc.subjectdeep vein thrombosis
dc.subjectneoplasm
dc.subjectpulmonary embolism
dc.subjectsex
dc.subjectvenous thromboembolism
dc.subject.meshAdult
dc.subject.meshAge Factors
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasms
dc.subject.meshRegistries
dc.subject.meshSex Factors
dc.subject.meshTime Factors
dc.subject.meshVenous Thromboembolism
dc.titleSex Differences in Patients With Occult Cancer After Venous Thromboembolism.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number24
dspace.entity.typePublication

Files